How much did Sotac Pharmaceuticals achieve in EBIT for the current year?
In the current year, Sotac Pharmaceuticals has achieved an EBIT of 68.45 M INR.
In 2024, Sotac Pharmaceuticals's EBIT was 68.45 M INR, a -701.03% increase from the -11.39 M INR EBIT recorded in the previous year.
YEAR | EBIT (undefined INR) |
---|---|
2022 | 68.45 |
2021 | -11.39 |
2020 | 4.62 |
Sotac Pharmaceuticals's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
A yearly comparison of Sotac Pharmaceuticals's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Sotac Pharmaceuticals's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Fluctuations in Sotac Pharmaceuticals’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
In the current year, Sotac Pharmaceuticals has achieved an EBIT of 68.45 M INR.
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Sotac Pharmaceuticals.
The EBIT of Sotac Pharmaceuticals has increased by -701.027% decreased compared to the previous year.
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
The EBIT of Sotac Pharmaceuticals is listed in the income statement.
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
Over the past 12 months, Sotac Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sotac Pharmaceuticals is expected to pay a dividend of 0 INR.
The current dividend yield of Sotac Pharmaceuticals is .
Sotac Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .
Sotac Pharmaceuticals paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 INR are expected. This corresponds to a dividend yield of 0 %.
Sotac Pharmaceuticals is assigned to the 'Health' sector.
To receive the latest dividend of Sotac Pharmaceuticals from 6/6/2024 amounting to 0 INR, you needed to have the stock in your portfolio before the ex-date on 6/6/2024.
The last dividend was paid out on 6/6/2024.
In the year 2023, Sotac Pharmaceuticals distributed 0 INR as dividends.
The dividends of Sotac Pharmaceuticals are distributed in INR.
Our stock analysis for Sotac Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sotac Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.